PL2564396T3 - Sposób wytwarzania izotopu - Google Patents

Sposób wytwarzania izotopu

Info

Publication number
PL2564396T3
PL2564396T3 PL11719186T PL11719186T PL2564396T3 PL 2564396 T3 PL2564396 T3 PL 2564396T3 PL 11719186 T PL11719186 T PL 11719186T PL 11719186 T PL11719186 T PL 11719186T PL 2564396 T3 PL2564396 T3 PL 2564396T3
Authority
PL
Poland
Prior art keywords
isotope preparation
isotope
preparation
Prior art date
Application number
PL11719186T
Other languages
English (en)
Inventor
Jan Roger Karlson
Peer Børretzen
Original Assignee
Bayer As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer As filed Critical Bayer As
Publication of PL2564396T3 publication Critical patent/PL2564396T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F13/00—Compounds of radium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/0005—Isotope delivery systems
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/001—Recovery of specific isotopes from irradiated targets
    • G21G2001/0094—Other isotopes not provided for in the groups listed above

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Inorganic Chemistry (AREA)
  • Geology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Radiation-Therapy Devices (AREA)
PL11719186T 2010-04-30 2011-04-29 Sposób wytwarzania izotopu PL2564396T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB201007354A GB201007354D0 (en) 2010-04-30 2010-04-30 Method
PCT/EP2011/002155 WO2011134671A1 (en) 2010-04-30 2011-04-29 Isotope preparation method
EP20110719186 EP2564396B1 (en) 2010-04-30 2011-04-29 Isotope preparation method

Publications (1)

Publication Number Publication Date
PL2564396T3 true PL2564396T3 (pl) 2015-10-30

Family

ID=42289984

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11719186T PL2564396T3 (pl) 2010-04-30 2011-04-29 Sposób wytwarzania izotopu

Country Status (23)

Country Link
US (3) US8926943B2 (pl)
EP (2) EP2564396B1 (pl)
JP (3) JP5973421B2 (pl)
KR (2) KR101886884B1 (pl)
CN (2) CN105654999B (pl)
AU (1) AU2011247361B2 (pl)
BR (1) BR112012027929B1 (pl)
CA (1) CA2797898C (pl)
DK (1) DK2564396T3 (pl)
EA (2) EA201590442A1 (pl)
ES (1) ES2539135T3 (pl)
GB (1) GB201007354D0 (pl)
HK (2) HK1183558A1 (pl)
HR (1) HRP20150577T1 (pl)
IL (1) IL222763B (pl)
MX (1) MX2012012670A (pl)
NZ (2) NZ700258A (pl)
PL (1) PL2564396T3 (pl)
PT (1) PT2564396E (pl)
RS (1) RS54089B1 (pl)
SG (2) SG10201503317RA (pl)
SI (1) SI2564396T1 (pl)
WO (1) WO2011134671A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201002508D0 (en) 2010-02-12 2010-03-31 Algeta As Product
GB201007353D0 (en) * 2010-04-30 2010-06-16 Algeta Asa Method
GB201007354D0 (en) * 2010-04-30 2010-06-16 Algeta Asa Method
US20150343099A1 (en) 2012-12-19 2015-12-03 Bayer Pharma Aktiengesellschaft Combination comprising radium-223 for the treatment of cancer
GB201314718D0 (en) * 2013-08-16 2013-10-02 Algeta As Quantification method
WO2015082378A1 (en) 2013-12-03 2015-06-11 Bayer Pharma Aktiengesellschaft Combination of pi3k-inhibitors
EP3077002B1 (en) 2013-12-03 2020-04-22 Bayer Pharma Aktiengesellschaft Combination of pi3k-inhibitors
EP3143626A1 (en) * 2014-05-13 2017-03-22 Paul Scherrer Institut Production of 43sc radionuclide and radiopharmaceuticals thereof for use in positron emission tomography
WO2016083739A1 (fr) 2014-11-26 2016-06-02 Rhodia Operations Composition de lanthane et d'actinium-227
GB201600154D0 (en) * 2016-01-05 2016-02-17 Bayer As Isotope preparation method
GB201600153D0 (en) * 2016-01-05 2016-02-17 Bayer As Isotope preparation method
AR110995A1 (es) 2017-02-24 2019-05-22 Bayer Ag Combinación de inhibidores de quinasa atr con sal de radio-223
KR102211812B1 (ko) * 2019-07-23 2021-02-04 한국원자력의학원 액화 라듐을 이용한 악티늄 생산 방법
RU2752845C1 (ru) * 2020-05-13 2021-08-11 Акционерное Общество "Наука И Инновации" Способ получения высокочистого радия-223

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390517A (en) * 1979-12-19 1983-06-28 New England Nuclear Corporation Method, composition and kit for stabilizing radiolabeled compounds
US5246591A (en) * 1990-07-13 1993-09-21 Pact, Incorporated Separation of metal ions on an anion exchange resin by chromatographic elution
WO1993009816A1 (en) * 1991-11-14 1993-05-27 Battelle Memorial Institute Method for diagnosing and treating cancer
DE69610597T3 (de) * 1995-03-03 2005-11-03 Alltech Associates, Inc., Deerfield Verfahren und vorrichtung zur elektrochemischen veränderung von chromatographiematerial
US5809394A (en) * 1996-12-13 1998-09-15 Battelle Memorial Institute Methods of separating short half-life radionuclides from a mixture of radionuclides
JP3832961B2 (ja) * 1998-03-10 2006-10-11 ユニチカ株式会社 ラジウム吸着剤の再生方法
NO310544B1 (no) * 1999-01-04 2001-07-23 Algeta As Opparbeidelse og anvendelse av radium-223 til fremstilling av preparat samt kit til behandling av kalsifisert vev for palliasjon, benkreft-terapi og/eller overflatebehandling av ben
CN1147602C (zh) * 2001-09-10 2004-04-28 中国原子能科学研究院 一种放射性同位素镉-109的制备工艺
US7157022B2 (en) 2002-09-30 2007-01-02 .Pg Research Foundation, Inc. Multivalent metal ion extraction using diglycolamide-coated particles
GB0308407D0 (en) * 2003-04-11 2003-05-21 Amersham Plc Method of obtaining 68 GA
NZ606996A (en) * 2003-04-15 2014-08-29 Algeta As Thorium-227 for use in radiotherapy of soft tissue disease
JP2005154700A (ja) * 2003-11-21 2005-06-16 Tatsuya Suzuki クラウンエーテル構造を官能基として側鎖に有するフェノール誘導体の有機高分子
TWI375660B (en) * 2004-01-22 2012-11-01 Semequip Inc Isotopically-enriched boranes and methods of preparing them
US20070009409A1 (en) * 2005-07-11 2007-01-11 Hariprasad Gali 212Bi or 213Bi Generator from supported parent isotope
DE102006008023B4 (de) * 2006-02-21 2008-05-29 Actinium Pharmaceuticals, Inc. Verfahren zum Reinigen von 225Ac aus bestrahlten 226Ra-Targets
JP4877863B2 (ja) * 2008-06-30 2012-02-15 独立行政法人日本原子力研究開発機構 キレート交換樹脂を用いた放射性銅の分離方法
GB201007354D0 (en) * 2010-04-30 2010-06-16 Algeta Asa Method

Also Published As

Publication number Publication date
JP5973421B2 (ja) 2016-08-23
US8926943B2 (en) 2015-01-06
CA2797898C (en) 2018-10-09
KR101886884B1 (ko) 2018-08-08
KR20130111931A (ko) 2013-10-11
DK2564396T3 (da) 2015-06-22
RS54089B1 (en) 2015-10-30
CN103003889A (zh) 2013-03-27
EP2564396B1 (en) 2015-05-20
KR20180038575A (ko) 2018-04-16
US20130136690A1 (en) 2013-05-30
NZ700258A (en) 2014-12-24
CA2797898A1 (en) 2011-11-03
US20210387861A1 (en) 2021-12-16
CN105654999A (zh) 2016-06-08
JP2013530384A (ja) 2013-07-25
MX2012012670A (es) 2013-03-08
PT2564396E (pt) 2015-07-23
EA201590442A1 (ru) 2015-11-30
ES2539135T3 (es) 2015-06-26
SG10201503317RA (en) 2015-06-29
SG185105A1 (en) 2012-12-28
JP2016156839A (ja) 2016-09-01
IL222763A0 (en) 2012-12-31
EA022498B1 (ru) 2016-01-29
WO2011134671A1 (en) 2011-11-03
BR112012027929B1 (pt) 2021-10-26
EP2854137A1 (en) 2015-04-01
BR112012027929A2 (pt) 2017-03-21
EA201291060A1 (ru) 2013-05-30
NZ603459A (en) 2014-10-31
CN105654999B (zh) 2019-01-04
GB201007354D0 (en) 2010-06-16
US20150104386A1 (en) 2015-04-16
SI2564396T1 (sl) 2015-08-31
HK1225851A1 (zh) 2017-09-15
AU2011247361B2 (en) 2014-09-18
EP2564396A1 (en) 2013-03-06
CN103003889B (zh) 2016-01-20
HRP20150577T1 (hr) 2015-08-14
HK1183558A1 (zh) 2013-12-27
JP2018159716A (ja) 2018-10-11
IL222763B (en) 2020-04-30

Similar Documents

Publication Publication Date Title
HK1183558A1 (zh) 同位素製備方法
SG184797A1 (en) Q tomography method
GB201001833D0 (en) Method
HK1183557A1 (en) Isotope production method
GB201009237D0 (en) New administration method
GB201011513D0 (en) Method
GB201004759D0 (en) Method
GB201012148D0 (en) Method
GB201006306D0 (en) Method
GB201010855D0 (en) Method
GB201002409D0 (en) Methods
GB201012784D0 (en) Method
GB201007207D0 (en) Method
GB201017003D0 (en) Method
GB201007522D0 (en) Method
GB201021940D0 (en) Method
GB201021435D0 (en) Method
GB201021028D0 (en) Method
GB201020257D0 (en) Method
GB201020072D0 (en) Method
GB201017574D0 (en) Method
GB201016858D0 (en) Method
GB201016856D0 (en) Method
GB201014632D0 (en) Method
GB201014556D0 (en) Method